InvestLog
ABCL AbCellera Biologics Inc. logo

ABCL AbCellera Biologics Inc.

Healthcare
$5.20+1.17%ClosedMarket Cap: $1.59B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

155

13F Shares

108,411,289

Ownership %

36.3%

New Positions

29

Increased Positions

78

Closed Positions

30

Reduced Positions

42

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
SILXETFMG Prime 2x Daily Junior Silver Miners ETF92,3793.81%
VALT81,5113.09%
IDNAiShares Genomics Immunology and Healthcare ETF372,1900.84%
BBCVirtus Biotech Clinical Trials ETF75,3270.75%
IPORenaissance IPO ETF28,6380.10%
IBBQInvesco Nasdaq Biotechnology ETF17,8280.08%
IBBiShares Biotechnology ETF1,732,0220.07%
GWXState Street SPDR S&P International Small Cap ETF164,3250.07%
BIBProShares - Ultra Nasdaq Biotechnology13,5620.06%
PDNInvesco RAFI Developed Markets ex-U.S. Small-Mid ETF42,5670.04%
ONEQFidelity Nasdaq Composite Index ETF132,4300.01%
AVSCAvantis U.S. Small Cap Equity ETF39,8040.01%
SPDWState Street SPDR Portfolio Developed World ex-US ETF564,8880.01%
AVUSAvantis U.S. Equity ETF64,8110.00%